Hemostats Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-1555 | Report Format : | Status : Upcoming |

Abstract

Global Hemostats Market: Overview

The hemostat is also known as arterial forceps or hemostatic clamp. It is a surgical tool that is used during major surgical procedures in order to control blood loss or halt bleeding during surgery. It is basically used in the early phases of surgery for an initial incision that closes blood vessels until ligation. Hemostats consist of a group of instruments that include pivot, tissue holders, needle holders, and various clamps. Reduce blood loss by hemostasis is the major challenge in any surgery. It can be achieved by various methods such as flowable and sealants, mechanical methods, active agents, thermal energy based devices, topical hemostatic agents, pharmaceutical agents, and thermal energy based devices. This procedure ensures strong adhesion of wound edges, rapid cessation of blood loss, tight sealing, prompt closure, reduced scarring, rapid healing, and reduced risk of infection.

Global Hemostats Market: Growth Factors

The hemostat clinical practice is growing very rapidly across the world thus anticipating boosting the global hemostats market growth. It offers lucrative growth opportunities for the market growth due to the presence of a pool of patients throughout the world. The affordable price of the tools expects to fuel the market growth. The surgical staple is the widely used tool to close the wounds. Topical hemostatic agents are broadly preferred as an alternative to standard suturing techniques in order to halt bleeding.

Global Hemostats Market: Segmentation

The global hemostats market is bifurcated on the basis of product type and region. The product type segment includes gelatin-based hemostats, thrombin-based, collagen-based hemostats, oxidized regenerated cellulose based hemostats, and combination hemostats. The regional breakdown of the hemostats market is given by North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Global Hemostats Market: Regional Analysis

North America is the leading consumer of the hemostats which is followed by Europe and Asia-Pacific region. Various strategies are adopted by the market players such as joint ventures, new product launches, agreements, partnerships, and collaborations in order to enhance the market revenue in the North America which contributes to the market growth. Increasing healthcare infrastructure coupled with rise in the number of surgeries is projected to propel the market in Europe. Asia-Pacific is the fastest growing region owing to increasing number of surgeries and change in regulatory policies encourages the market in the region. Other major factors propelling the global hemostats market growth are swift adoption of innovative products, early adoption of highly developed technologies, and improved healthcare facilities in the region.

Global Hemostats Market: Competitive Players

The key market players that are dominating the hemostats market include Anika Therapeutics, Inc., C.R. Bard, B. Braun Melsungen, Pfizer, 3-D Matrix, Ltd., Medtrade Products Ltd., Stryker, Baxter, Integra Lifesciences Corporation, Resorba Medical GmbH., and Vascular Solutions, Inc. Other influencing market players in the market are Gamma Therapeutics, Inc., Arch Therapeutics Inc., CSL Behring, Equimedical, B.V., Biom’Up SAS, Medline Industries, Inc., Hemostasis, LLC, CryoLife, Inc., Mallinckrodt Plc., Hemostasis, LLC, and Hemotec Medical GmbH.

Global Hemostats Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Vitreous Tamponades Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2539 | Report Format:

Global Vitreous Tamponades Market: Overview Vitreous tamponades are the postoperative devices utilized in the retinal detachment vitrectomy processes. Retinal detachment is extremely grave medical condition and if not taken care of on time, can result in eternal vision loss. Vitrectomy is a surg...Read More

Operating Room Equipment Market by Product (Anesthesia Devices, Endoscopes, Operating room Lights, Operating Tables, Electrosurgical Devices, Surgical Imaging Devices and Patient Monitors), For Hospitals, Outpatient Facilities and Ambulatory Surgical Centers: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016-2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2515 | Report Format:

The operating room equipment market report includes comprehensive and profound analysis on the global and regional level. The report gives historic data of 2014 along with a forecast from 2017 to 2022 based on revenue (USD Billion). The study comprises drivers, restraints, and opportunities for th...Read More

Heart Valve Devices Market by Procedure (Heart Valve Replacement Devices (Mechanical Valve, Bioprosthetic Valve, TAVR) & Position (Mitral Valve, Aortic Valve, Other), Heart valve Repair Devices (Surgical Valve, Balloon Valvuloplasty Devices, TMVR)), by End User (Hospitals and Ambulatory Surgical Centers), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016- 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2511 | Report Format:

The report covers forecast and analysis for the Heart Valve Devices Market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the heart valve devices market ...Read More

Choose License Type:
Latest Published Reports

View All Published Reports